Clinical Documentation Tip: Atrial Fibrillation

Slides:



Advertisements
Similar presentations
UCLA Family Medicine Department IMG Program Carlos Yoo.
Advertisements

New Atrial Fibrillation/Flutter Pathway and GRASP Tool
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
A GRADUATING RESEARCH PROJECT FOR THE BACHALOLIC DEGEES.
{ Cardioversion turns 50 Seth Bilazarian MD Private practice theheart.org.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
What to do if called for an arrhythmia
Atrial Fibrillation Update 2012 Dr C Seifer Section of Cardiology St Boniface Hospital.
Phillip H. Lam, M.D. Chief Medical Resident Medstar Georgetown University Hospital.
Atrial fibrillation Daniel Gutenberger M.D. Chief Medical Director American General, Milwaukee.
Arrhythmias: The Good, the Bad and the Ugly
Atrial Fibrillation. Outline Epidemiology Signs and Symptoms Etiology Differential Diagnosis Diagnostic Tests Classification Management.
Telemetry/ACLS review
NILOFAR RAHMAN, MD AMIT KUMAR, MD. DEFINITION  A SVT with uncoordinated atrial activation with constant deterioration of atrial mechanical function 
Ablation for Paroxysmal Atrial Fibrillation (APAF) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Carlo.
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION St. Mary’s Hospital February – August 2007.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Central Sleep Apnea Problem Based Learning Module Vidya Krishnan, and Sutapa Mukherjee for the Sleep Education for Pulmonary Fellows and Practitioners,
HUP DEPARTMENT DATE Handoff Safety Curriculum. “Handoffs and Sign-Out” Verbal and Written  Review the importance of handoffs  Watch and critique videos.
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Current Management Strategies.
Management of Postoperative Atrial Fibrillation
Atrial Fibrillation DR. DAYANAND NAIK, MD, FACC; CLINICAL ASSOCIATE PROFESSOR, NEW YORK MEDICAL COLLEGE.
An Unusual Case Of Recurrent Atrial Fibrillation Mark Linzer MD Section of GIM Scholars GIM Conference
Barts and The London NHS Trust NHS Barts and The London NHS Trust NHS AF ablations at SBH August 2008 – August 2009 Patients undergoing first ablation.
The Transition to What you need to know for Endocrinology Date | Presenter Information.
Redo afib ablation John R Onufer MD FHRS
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
VCU Department of Surgery Death & Complications Conference
 M&M EDUCATIONAL CASE REVIEW Date 1.  CASE # 2.
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
Documentation Tips Susan Sabu RN, BSN Clinical Document Improvement Specialist Critical Care, Trauma, Cardiology, PACU.
1 Tedisamil for Conversion of Atrial Fibrillation Thomas A. Marciniak, M.D. Division of Cardiovascular and Renal Products U.S. Food & Drug Administration.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH.  All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Daily Report John Feng, MD HPI: 60 YO M no pmhx 1 week of epigastric pain that is constant, worse with exertion, better with food, started.
Journal of the American College of Cardiology Vol. 61, No. 4, 2013 Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation.
Cardiac Arrhythmias Name That Rhythm Kathaleen Johnson DNP, CRNP, CCRN.
Contemporary Atrial Fibrillation Management
Risk Stratification of Chest Pain: Best Practices
AF Basics for Office Visits Patient Education
David Sanders Mini-Lecture 2017
Blood transfusion: When to transfuse and risks involved
American College of Cardiology Presented by Dr. Stuart J. Connolly
Guide on how to manage atrial fibrillation in the office
The accuracy of clinical coding in a large DGH in East London
Therapeutics 1 Tutoring
Clinical Documentation Tip: Acute Encephalopathy
Volume 14, Issue 6, Pages (June 2017)
The Atrial Fibrillation Clinic in Llanelli
JN 71 yo F.
Morbidity and Mortality Conference
Education and Communication with Physicians
The Research Question Can a childhood obesity behavior modification program be implemented in primary care practices? Can participation in a childhood.
Volume 14, Issue 6, Pages (June 2017)
Electronic Resources for Clinical Faculty
Dhanunjaya Lakkireddy et al. JACEP 2015;1:
Clinical Documentation Improvement Program In-Patient Status
Atrial Fibrillation: I’ve seen it all!
Stavros Stavrakis et al. JACEP 2015;1:1-13
Clinical importance of short–long–short sequences: Analysing the mode of onset of ventricular tachycardias and atrial fibrillation  Bulent Gorenek  International.
Pouria Alipour et al. JACEP 2017;j.jacep
The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.
Atrial Fibrillation, AntiCoagulation
NICE 2014 Check pulse in patients presenting with:
Volume 14, Issue 6, Pages (June 2017)
Presentation transcript:

Clinical Documentation Tip: Atrial Fibrillation Freddy Santoso, CCS, CCDS

Definitions

Clinical Example – “Mr. Smith” HPI: 88 y M with h/o HTN, dysphagia admitted with dyspnea and productive cough. Overnight developed Afib with RVR P/E: Tachycardia to 140s Lab: EKG = Afib; CXR = RLL consolidation Rx: Antibiotics started on admit. Metoprolol, diltiazem, amiodarone bolus/gtt without good response x7 days; started apixaban; Cards consult - family declined any TEE/cardioversion or ablation as patient asymptomatic

Documentation Impact Aspiration PNA “AFib w/ RVR” POOR GOOD Aspiration PNA “AFib w/ RVR” filler filler filler fillerfi Expected Length of Stay = 3 Days Aspiration PNA Persistent Afib w/ RVR Expected Length of Stay = 5 Days

Clinical Example – “Mrs. Smith” HPI: 55 y F no significant PMH p/w SOB, chest tightness x 2 weeks. P/E: Tachycardia 140s-160s. BMI 44 Lab: EKG: Afib Rx: Metoprolol, diltiazem uptitrated to no effect; day #2 Cardiology consult; heparin started; underwent successful DC cardioversion day #4

Documentation Impact “Afib w/ RVR” “BMI 44” POOR GOOD “Afib w/ RVR” “BMI 44” Expected Length of Stay = 2 Days Persistent Afib Morbid obesity with BMI 44 Expected Length of Stay = 3 Days

Key Points Avoid “Afib” or “pAF” – nonspecific/ambiguous Use “paroxysmal” if < 7 days Use “persistent” if > 7 days or if > 48 hours + decision to cardiovert (electrically or pharmarcologically) Use “longstanding persistent” if > 12 months (not just ‘longstanding’)

THANK YOU ! ANY QUESTIONS ?